NCT01887795View on ClinicalTrials.gov

Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study

PHASE3CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Multiple Brain MetastasesNon-small-cell Lung Cancer
Interventions
DRUG

Erlotinib

DRUG

WBRT

Trial Locations (1)

Unknown

Zhenzhou-Yang, Chongqing

All Listed Sponsors
lead

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

OTHER

NCT01887795 - Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study | Biotech Hunter | Biotech Hunter